2Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation. Br J Dermatol, 1986, 114(5) :583 -590.
3Sabroe RA, Seed PT, Francis DM, et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti - lgE autoantibodies. J Am Acad Dermatol,1999,40(3) :443 -450.
4Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon) Rlalpha (alpha-subunit)in chronic urticaria. J Allergy Clin Immunol, 1998, 101 (5) :672 -676.
5Fiebiger E, Hammerschmid F, Stingl G, et al. Anti-FeepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of astructure-function relationship. J Clin Invest, 1998, 101 (1) :243 -251.
6Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol, 1996, 106(5) :1001 -1006.
7Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histanline release in chronic urticaria. J Allergy Clin Inununol, 1999,104(1) :169 -172.
8Tong LJ, Balakrishnan G, Kochan .]P, et al. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Inununol,1997, 99(4) :461 -465.
9ODonnell BF, ONeill CM, Francis DM, et al. Human leucocyte antigen class Ⅱ associations in chronic idiopathic urticaria. Br J Dermatol,1999. 140(5) :853 -858.
10Sabroe RA, Poon E, Orchard GE, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepailonRI or anti-IgE autoantibodies. J Allergy Clin Immunol, 1999, 103 (3 Pt 1 ) :484 - 493.
